ABOUT ETOPOSIDE

In August 2022 enrollment started over a review analyzing the outcome of semaglutide on tau accumulation within the brains of people who find themselves amyloid-good, with or without having diabetes, and without any or mild cognitive impairment (Koychev et al., 2024). The study on the University of Oxford within the U.K. will deal with 88 individua